euroPLX Boosts Pharma Business Development in Difficult Times

Valletta, Malta, March 2, 2010. More than 200 pharma and biotech industry delegates from 37 countries, four continents, convened at euroPLX 42 Valletta for pharma deals, organisers reported today. The leading partnering event for pharma and biopharma business development arranged an average of 24.6 pre-scheduled one-on-one negotiations per participating company on two conference days.

For the organisers, RauCon business development, this is a clear sign that the pragmatic euroPLX concept is favoured in difficult economic times, owing to its unique results-to-cost ratio.

The next euroPLX event will be euroPLX 43 Berlin, to be held on 14 and 15 June, 2010, in the Ellington Hotel, which is located right in the centre of Berlin, with many famous places in walking distance. Dinner sponsors for this event will be Dr. Kade Pharmazeutische Fabrik GmbH and Berlin-Chemie AG, a subsidiary of Menarini.

The partnering event is rapidly filling and an early registration bonus of EUR 200 will be granted for registrations received by 14 April, 2010. The growing list of registered companies is displayed on